Medicare Enrolled
Dr. Kali Eswaran, M.D.
Internal Medicine · Rancho Cordova, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eswaran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eswaran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eswaran
Dr. Kali Eswaran is an internal medicine specialist in Rancho Cordova, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Eswaran performed 1,894 Medicare services across 1,229 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eswaran received a total of $7,578 from 41 pharmaceutical and/or device companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eswaran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in CA
$7,578 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,894
Medicare services
Top 17% in CA for internal medicine
1,229
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~95 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
571 | $89 | $155 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
357 | $41 | $75 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
194 | $138 | $225 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
176 | $54 | $115 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
110 | $134 | $230 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
102 | $33 | $35 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
89 | $76 | $80 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
60 | $81 | $150 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
32 | $58 | $150 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
32 | $196 | $300 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
29 | $33 | $35 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
28 | $51 | $100 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
24 | $283 | $350 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
23 | $154 | $535 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $12 | $50 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
13 | $33 | $40 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
13 | $52 | $302 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $193 | $325 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
11 | $122 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
4.1% medium
94.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,578
Total received (2018-2024)
Avg $1,083/year across 7 years
Top 12% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
354
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,578 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$576
2023
$1,244
2022
$1,575
2021
$1,213
2020
$760
2019
$1,151
2018
$1,060
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$212
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$66
Lilly USA, LLC
$47
GlaxoSmithKline, LLC.
$42
Exact Sciences Corporation
$33
Abbott Laboratories
$29
Novo Nordisk Inc
$22
Alnylam Pharmaceuticals Inc.
$22
PFIZER INC.
$20
Janssen Pharmaceuticals, Inc
$18
Top 3 companies account for 59.7% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,300
AstraZeneca Pharmaceuticals LP
$880
GlaxoSmithKline, LLC.
$738
PFIZER INC.
$519
Novo Nordisk Inc
$416
Kowa Pharmaceuticals America, Inc.
$357
Amarin Pharma Inc.
$351
Bayer HealthCare Pharmaceuticals Inc.
$287
Novartis Pharmaceuticals Corporation
$277
Lilly USA, LLC
$235
Teva Pharmaceuticals USA, Inc.
$233
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$194
Merck Sharp & Dohme Corporation
$167
Nestle HealthCare Nutrition Inc.
$163
Ironwood Pharmaceuticals, Inc
$133
Vanda Pharmaceuticals Inc.
$133
Janssen Pharmaceuticals, Inc
$120
ABBVIE INC.
$117
NESTLE HEALTHCARE NUTRITION INC.
$115
E.R. Squibb & Sons, L.L.C.
$95
Exact Sciences Corporation
$89
SANOFI-AVENTIS U.S. LLC
$74
Bayer Healthcare Pharmaceuticals Inc.
$66
Amgen Inc.
$64
AbbVie Inc.
$58
Allergan, Inc.
$50
AbbVie, Inc.
$42
Merck Sharp & Dohme LLC
$37
Alfasigma USA, Inc.
$32
IDORSIA PHARMACEUTICALS US INC
$31
Abbott Laboratories
$29
Intercept Pharmaceuticals, Inc.
$27
Astellas Pharma US Inc
$22
Alnylam Pharmaceuticals Inc.
$22
IRONWOOD PHARMACEUTICALS, INC
$20
Dova Pharmaceuticals
$17
Biohaven Pharmaceuticals, Inc.
$16
Qiagen, LLC
$15
Zealand Pharma US, Inc.
$15
Allergan Inc.
$13
Bardy Diagnostics, Inc.
$8
Top 3 companies account for 38.5% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYDUREON · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CREON · Carnation Ambulatory Monitor · Cologuard Collection Kit · Creon · DUZALLO · Doptelet · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FREESTYLE LIBRE 3 · GARDASIL 9 · HETLIOZ · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LIVALO · LYRICA · Linzess · Livalo · MDX QUANTIFERON · MOUNJARO · MYRBETRIQ · NURTEC ODT · OCALIVA · OFEV · ONPATTRO · Ozempic · PNEUMOVAX 23 · PRALUENT · PREVNAR - 13 · PREVNAR 20 · QUVIVIQ · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · TRELEGY ELLIPTA · TRULANCE · TRULICITY · UBRELVY · VERQUVO · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Victoza · XARELTO · XIFAXAN · ZEGALOGUE · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
1,150
Per 100K population
72.6
County median income
$88,724
Nearest hospital
MERCY SAN JUAN MEDICAL CENTER
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eswaran is a clinical cardiology specialist, with above-average Medicare volume (top 17% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eswaran experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Eswaran performed 571 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eswaran receive payments from pharmaceutical companies?
Yes. Dr. Eswaran received a total of $7,578 from 41 companies across 354 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eswaran's costs compare to other internal medicine physicians in Rancho Cordova?
Dr. Eswaran's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eswaran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Rancho Cordova
Browse internal medicine physicians in Rancho Cordova ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology